Industry News
How blood group O protects against malaria
3/11/2015
It has long been known that people with blood type O are protected from dying of severe malaria.
Chromosomal rearrangement is the key to progress against aggressive infant leukemia
3/11/2015
St. Jude Children's Research Hospital -- Washington University Pediatric Cancer Genome Project study highlights need for targeted therapies against a rare infant leukemia with a poor prognosisThe...
Review article provides new insights on how tumors metastasize
3/11/2015
In a review article recently published in the journal Clinical and Translational Medicine, researchers from Boston University School of Medicine (BUSM) shed new light on the underlying processes of...
After breast cancer diagnosis, risk of thyroid cancer goes up
3/11/2015
Breast cancer survivors are at increased risk of developing thyroid cancer, especially within five years of their breast cancer diagnosis, according to a new analysis of a large national database.
Risk of breast cancer in transgender persons -- a study of veterans
3/11/2015
A study of breast cancer in transgender veterans has identified ten new cases, increasing the total number of published cases in both female-to-male and male-to-female transgender persons.
ASH report: 'Systems-based' hematologist is new way to provide hematology expertise
3/11/2015
Proposed models of centralized position align with rapidly changing health-care system, offer a sustainable approach to recruit and retain talent to fieldA report, just released by the American...
New oral treatment for chronic lymphocytic leukaemia now approved for use within NHS Scotland
3/10/2015
Gilead Sciences, Inc. has announced that the Scottish Medicines Consortium (SMC) has approved Zydelig (idelalisib) - a new oral treatment - for adult patients with chronic lymphocytic leukaemia...
VolitionRx initiates second prostate cancer pilot study assessing Nucleosomics(R) technology
3/10/2015
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has initiated a pilot...
Thyroid nodule identification: new data supporting use of ThyraMIR announced
3/10/2015
PDI, Inc. subsidiary, Interpace Diagnostics, has announced new data supporting the use of combination platform testing with ThyraMIR, the first and only microRNA expression classifier, and ThyGenX...
To develop a device based on nanophotonic technology that enables a quick and early diagnosis of different types of cancer - specifically breast, prostate, lung and colorectal - analysing only two...